The drop comes the day after the drugmaker said it would add a so-called black-box warning to its gene therapy Elevidys after ...

The FDA will request Sarepta Therapeutics stop all shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy, ...

Sarepta Therapeutics (SRPT) stock falls as the FDA reviews if the company's gene therapy Elevidys should remain on the market following patient deaths. Read more here.

A third patient has died this year after getting a gene therapy from Sarepta Therapeutics Inc., raising questions about the ...